View in EDS

Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.

Saved in:
Bibliographic Details
Title: Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.
Authors: Watchmaker PB; Department of Neurosurgery, University of California, San Francisco., Colton M; Department of Neurosurgery, University of California, San Francisco., Pineo-Cavanaugh PL; Department of Neurosurgery, University of California, San Francisco., Okada H; Department of Neurosurgery, University of California, San Francisco.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
Source: Current opinion in oncology [Curr Opin Oncol] 2022 Nov 01; Vol. 34 (6), pp. 661-669. Date of Electronic Publication: 2022 Jul 19.
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9007265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-703X (Electronic) Linking ISSN: 10408746 NLM ISO Abbreviation: Curr Opin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35855503
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Watchmaker+PB%22">Watchmaker PB</searchLink>; Department of Neurosurgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Colton+M%22">Colton M</searchLink>; Department of Neurosurgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Pineo-Cavanaugh+PL%22">Pineo-Cavanaugh PL</searchLink>; Department of Neurosurgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Okada+H%22">Okada H</searchLink>; Department of Neurosurgery, University of California, San Francisco.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007265%22">Current opinion in oncology</searchLink> [Curr Opin Oncol] 2022 Nov 01; Vol. 34 (6), pp. 661-669. <i>Date of Electronic Publication: </i>2022 Jul 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007265 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1531-703X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210408746%22">10408746 </searchLink><i>NLM ISO Abbreviation: </i>Curr Opin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35855503
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/CCO.0000000000000877
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 661
    Titles:
      – TitleFull: Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Watchmaker PB
      – PersonEntity:
          Name:
            NameFull: Colton M
      – PersonEntity:
          Name:
            NameFull: Pineo-Cavanaugh PL
      – PersonEntity:
          Name:
            NameFull: Okada H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2022 Nov 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1531-703X
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Current opinion in oncology
              Type: main
ResultId 1